Toggle Main Menu Toggle Search

Open Access padlockePrints

A functional variant in the core promoter of the CD95 cell death receptor gene predicts prognosis in acute promyelocytic leukemia

Lookup NU author(s): Dr Sarah FordhamORCiD, Dr Victoria Forster, Professor Graham Jackson, Dr Simon BomkenORCiD, Professor James Allan


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Up to 15% of acute promyelocytic leukemia (APL) patients fail to achieve or maintain remission. We investigated a common G > A polymorphism at position -1377 (rs2234767) in the core promoter of the CD95 cell death receptor gene in 708 subjects with acute myeloid leukemia, including 231 patients with APL. Compared with the GG genotype, carrier status for the -1377A variant was associated with a significantly worse prognosis in APL patients. Carriers were more likely to fail remission induction (odds ratio = 4.22; 95% confidence interval, 1.41-12.6, P = .01), were more likely to die during the first 8 weeks of remission induction therapy (hazard ratio = 7.26; 95% confidence interval, 2.39-22.9, P = .0005), and had a significantly worse 5-year overall survival (odds ratio = 2.14; 95% confidence interval, 1.10-4.15, P = .03). The -1377A variant destroys a binding site for the SP1 transcriptional regulator and is associated with lower transcriptional activity of the CD95 promoter. Identifying patients at high risk of life-threatening events, such as remission induction failure, is a high priority in APL, especially because such events represent a major cause of death despite the introduction of differentiation therapy. (Blood. 2012; 119(1): 196-205)

Publication metadata

Author(s): Sunter NJ, Scott K, Hills R, Grimwade D, Taylor S, Worrillow LJ, Fordham SE, Forster VJ, Jackson G, Bomken S, Jones G, Allan JM

Publication type: Article

Publication status: Published

Journal: Blood

Year: 2012

Volume: 119

Issue: 1

Pages: 196-205

Print publication date: 14/11/2011

ISSN (print): 0006-4971

ISSN (electronic): 1528-0020

Publisher: American Society of Hematology


DOI: 10.1182/blood-2011-04-349803


Altmetrics provided by Altmetric


Funder referenceFunder name
MRC/NCRI Adult Leukaemia Working Party
Guy's and St Thomas' Hospital Charity
06002Leukaemia & Lymphoma Research (United Kingdom)
11006Leukaemia & Lymphoma Research (United Kingdom)